Advertisement
Screener

Revolution Medicines, Inc. (RVMD) Net Margin

Revolution Medicines, Inc. (RVMD) Net Margin

  • 2023-12-31: Net Margin -21770.49%.
  • 2023-06-30: Net Margin -2570.55%.
  • 2023-03-31: Net Margin -970.89%.
  • 2022-12-31: Net Margin -368.60%.

Complete source-backed net margin history.

Available history
2018-12-31 to 2023-12-31
Data captured

Historical Net Margin

DateNet Margin
2023-12-31-21770.49%
2023-06-30-2570.55%
2023-03-31-970.89%
2022-12-31-368.60%
2022-09-30-2185.01%
2022-06-30-671.59%
2022-03-31-760.72%
2021-12-31-556.83%
2021-09-30-4808.36%
2021-06-30-509.30%
2021-03-31-366.95%
2020-12-31-390.86%
2020-09-30-215.00%
2020-06-30-271.47%
2020-03-31-169.05%
2019-12-31-120.75%
2019-09-30-102.49%
2019-06-30-82.40%
2019-03-31-76.95%

Annual Net Margin

DateNet Margin
2023-12-31-3768.28%
2022-12-31-702.95%
2021-12-31-636.58%
2020-12-31-251.63%
2019-12-31-95.25%
2018-12-31-207.24%

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIOGEN INC. (BIIB)United States$33.427B19.60
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29